Chronic inflammatory and neuropathic pain affects over 90% of patients with Type 2 diabetes (48, 49), and links between FGF13 and diabetic neuropathy in mouse models (50) and in humans (51) have been reported. This evidence concerns the gene FGF13 and diabetic neuropathy.